Autres langues SillaJen, Inc.

Actions

A215600

KR7215600008

Cours en clôture Korea S.E. Autres places de cotation 00:00:00 14/06/2024			Varia. 5j.	Varia. 1 janv.
3 550 ^KRW	-5,71 %		-11,58 %	-41,13 %

22/04	OSR Holdings et SillaJen signent un protocole d'accord pour collaborer au développement de produits thérapeutiques innovants et pénétrer le marché américain	CI
27/03	SillaJen, Inc. Soumet un CSR à la FDA américaine pour l'étude REN026 chez des patients atteints de RCC	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

OSR Holdings and SillaJen Enter into A Memorandum of Understanding to Collaborate the Development of Innovative Therapeutics and Enter the U.S. Market	22/04
SillaJen, Inc. Submits CSR to the US FDA for REN026 Study in Patients with RCC	27/03
SillaJen to Raise 129.4 Billion Won via Shares Issuance	25/03
SillaJen, Inc.(KOSDAQ:A215600) added to S&P Global BMI Index	18/09/23
Oncolytic Virus Competitive Landscape Clinical Trials, Growth, and Key Companies \| Companies- Genelux Corporation, Candel Therapeutics, CG Oncolgy, DNAtrix, SillaJen Biotherapeutics	08/06/23
Basilea announces transition milestone for oncology asset BAL0891 triggering milestone payment of USD 4 million by SillaJen	20/12/22
Basilea erreicht mit Transfer-Onkologiekandidat Meilenstein und erhält 4 Mio USD	19/12/22
Switzerland's Basilea Pharmaceutica Secures $4 Million Milestone Payment for Oncology Asset	19/12/22
SillaJen Resumes Trading on Kosdaq	13/10/22
SillaJen Bags Licensing Right to Basilea Pharmaceutica's Oncology Drug	21/09/22
Kosdaq Delists Biotechnology Company SillaJen	19/01/22
An unknown buyer agreed to acquire a 5.1% stake in NeoImmuneTech, Inc. from SillaJen, Inc. for KRW 10.1 billion.	25/11/21
SillaJen, Inc. announced that it has received KRW 40 billion in funding	31/08/21
SillaJen, Inc. announced that it has received KRW 60 billion in funding from M2N Co.,Ltd	15/07/21
SillaJen, Inc. announced that it expects to receive KRW 40 billion in funding	14/07/21
SillaJen, Inc. announced that it expects to receive KRW 60 billion in funding from M2N Co.,Ltd	31/05/21
M2N Co.,Ltd signed LOI to acquire SillaJen, Inc..	21/04/21
SillaJen, Inc.(KOSDAQ:A215600) dropped from S&P Global BMI Index	21/09/20
SillaJen, Inc.(KOSDAQ:A215600) dropped from FTSE All-World Index	21/09/20
SillaJen, Inc. announced that it has received KRW 20 billion in funding	24/04/20

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues SillaJen, Inc.

Actions

A215600

KR7215600008

Autres langues

Filtres